Chalice Brands Ltd.
Chalice Brands Ltd. (CHALF) Stock Competitors & Peer Comparison
See (CHALF) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CHALF | $0.00 | +0.00% | 11.6M | N/A | -$0.08 | N/A |
| MKGAF | $128.13 | +1.25% | 55.7B | 17.31 | $7.40 | +1.96% |
| MKKGY | $25.07 | -0.56% | 53.4B | 16.93 | $1.48 | +2.00% |
| TKPHF | $27.50 | +0.00% | 43B | 48.25 | $0.57 | +4.84% |
| IPSEY | $32.22 | +0.00% | 42.6B | 20.65 | $1.56 | +0.81% |
| HLNCF | $4.66 | -2.92% | 41.9B | 22.19 | $0.21 | +1.87% |
| SDZNY | $56.78 | -0.92% | 24.3B | -2825.00 | -$0.02 | +1.19% |
| ESALY | $61.51 | -2.11% | 17.6B | 20.54 | $3.00 | N/A |
| TEVJF | $14.00 | +0.00% | 16.1B | -93.33 | -$0.15 | N/A |
| SGIOY | $8.70 | +0.37% | 14.8B | 12.99 | $0.67 | +1.82% |
Stock Comparison
CHALF vs MKGAF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, MKGAF has a market cap of 55.7B. Regarding current trading prices, CHALF is priced at $0.00, while MKGAF trades at $128.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas MKGAF's P/E ratio is 17.31. In terms of profitability, CHALF's ROE is +0.00%, compared to MKGAF's ROE of +0.10%. Regarding short-term risk, CHALF is more volatile compared to MKGAF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check MKGAF's competition here
CHALF vs MKKGY Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, MKKGY has a market cap of 53.4B. Regarding current trading prices, CHALF is priced at $0.00, while MKKGY trades at $25.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas MKKGY's P/E ratio is 16.93. In terms of profitability, CHALF's ROE is +0.00%, compared to MKKGY's ROE of +0.10%. Regarding short-term risk, CHALF is more volatile compared to MKKGY. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check MKKGY's competition here
CHALF vs TKPHF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, TKPHF has a market cap of 43B. Regarding current trading prices, CHALF is priced at $0.00, while TKPHF trades at $27.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas TKPHF's P/E ratio is 48.25. In terms of profitability, CHALF's ROE is +0.00%, compared to TKPHF's ROE of +0.01%. Regarding short-term risk, CHALF is more volatile compared to TKPHF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check TKPHF's competition here
CHALF vs IPSEY Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, IPSEY has a market cap of 42.6B. Regarding current trading prices, CHALF is priced at $0.00, while IPSEY trades at $32.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas IPSEY's P/E ratio is 20.65. In terms of profitability, CHALF's ROE is +0.00%, compared to IPSEY's ROE of +0.17%. Regarding short-term risk, CHALF is more volatile compared to IPSEY. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check IPSEY's competition here
CHALF vs HLNCF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, HLNCF has a market cap of 41.9B. Regarding current trading prices, CHALF is priced at $0.00, while HLNCF trades at $4.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas HLNCF's P/E ratio is 22.19. In terms of profitability, CHALF's ROE is +0.00%, compared to HLNCF's ROE of +0.09%. Regarding short-term risk, CHALF is more volatile compared to HLNCF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check HLNCF's competition here
CHALF vs SDZNY Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, SDZNY has a market cap of 24.3B. Regarding current trading prices, CHALF is priced at $0.00, while SDZNY trades at $56.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas SDZNY's P/E ratio is -2825.00. In terms of profitability, CHALF's ROE is +0.00%, compared to SDZNY's ROE of +0.00%. Regarding short-term risk, CHALF is more volatile compared to SDZNY. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check SDZNY's competition here
CHALF vs ESALY Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, ESALY has a market cap of 17.6B. Regarding current trading prices, CHALF is priced at $0.00, while ESALY trades at $61.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas ESALY's P/E ratio is 20.54. In terms of profitability, CHALF's ROE is +0.00%, compared to ESALY's ROE of +0.06%. Regarding short-term risk, CHALF is more volatile compared to ESALY. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check ESALY's competition here
CHALF vs TEVJF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, TEVJF has a market cap of 16.1B. Regarding current trading prices, CHALF is priced at $0.00, while TEVJF trades at $14.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas TEVJF's P/E ratio is -93.33. In terms of profitability, CHALF's ROE is +0.00%, compared to TEVJF's ROE of -0.03%. Regarding short-term risk, CHALF is more volatile compared to TEVJF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check TEVJF's competition here
CHALF vs SGIOY Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, SGIOY has a market cap of 14.8B. Regarding current trading prices, CHALF is priced at $0.00, while SGIOY trades at $8.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas SGIOY's P/E ratio is 12.99. In terms of profitability, CHALF's ROE is +0.00%, compared to SGIOY's ROE of +0.05%. Regarding short-term risk, CHALF is more volatile compared to SGIOY. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check SGIOY's competition here
CHALF vs SGIOF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, SGIOF has a market cap of 14.3B. Regarding current trading prices, CHALF is priced at $0.00, while SGIOF trades at $16.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas SGIOF's P/E ratio is 12.53. In terms of profitability, CHALF's ROE is +0.00%, compared to SGIOF's ROE of +0.05%. Regarding short-term risk, CHALF is more volatile compared to SGIOF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check SGIOF's competition here
CHALF vs BIOVF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, BIOVF has a market cap of 10.3B. Regarding current trading prices, CHALF is priced at $0.00, while BIOVF trades at $29.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas BIOVF's P/E ratio is 23.09. In terms of profitability, CHALF's ROE is +0.00%, compared to BIOVF's ROE of +0.10%. Regarding short-term risk, CHALF is more volatile compared to BIOVF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check BIOVF's competition here
CHALF vs IPSEF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, IPSEF has a market cap of 9.4B. Regarding current trading prices, CHALF is priced at $0.00, while IPSEF trades at $113.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas IPSEF's P/E ratio is 18.19. In terms of profitability, CHALF's ROE is +0.00%, compared to IPSEF's ROE of +0.14%. Regarding short-term risk, CHALF is more volatile compared to IPSEF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check IPSEF's competition here
CHALF vs SFOSF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, SFOSF has a market cap of 9B. Regarding current trading prices, CHALF is priced at $0.00, while SFOSF trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas SFOSF's P/E ratio is 15.33. In terms of profitability, CHALF's ROE is +0.00%, compared to SFOSF's ROE of +0.06%. Regarding short-term risk, CHALF is more volatile compared to SFOSF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check SFOSF's competition here
CHALF vs ESAIY Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, ESAIY has a market cap of 8.3B. Regarding current trading prices, CHALF is priced at $0.00, while ESAIY trades at $7.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas ESAIY's P/E ratio is 26.36. In terms of profitability, CHALF's ROE is +0.00%, compared to ESAIY's ROE of +0.03%. Regarding short-term risk, CHALF is more volatile compared to ESAIY. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check ESAIY's competition here
CHALF vs ESALF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, ESALF has a market cap of 8.2B. Regarding current trading prices, CHALF is priced at $0.00, while ESALF trades at $29.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas ESALF's P/E ratio is 26.13. In terms of profitability, CHALF's ROE is +0.00%, compared to ESALF's ROE of +0.03%. Regarding short-term risk, CHALF is more volatile compared to ESALF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check ESALF's competition here
CHALF vs GZPHF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, GZPHF has a market cap of 6B. Regarding current trading prices, CHALF is priced at $0.00, while GZPHF trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas GZPHF's P/E ratio is 10.22. In terms of profitability, CHALF's ROE is +0.00%, compared to GZPHF's ROE of +0.07%. Regarding short-term risk, CHALF is more volatile compared to GZPHF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check GZPHF's competition here
CHALF vs HKMPF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, HKMPF has a market cap of 5.8B. Regarding current trading prices, CHALF is priced at $0.00, while HKMPF trades at $26.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas HKMPF's P/E ratio is 16.38. In terms of profitability, CHALF's ROE is +0.00%, compared to HKMPF's ROE of +0.16%. Regarding short-term risk, CHALF is more volatile compared to HKMPF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check HKMPF's competition here
CHALF vs HKMPY Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, HKMPY has a market cap of 5.7B. Regarding current trading prices, CHALF is priced at $0.00, while HKMPY trades at $51.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas HKMPY's P/E ratio is 15.99. In terms of profitability, CHALF's ROE is +0.00%, compared to HKMPY's ROE of +0.16%. Regarding short-term risk, CHALF is more volatile compared to HKMPY. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check HKMPY's competition here
CHALF vs SGFEF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, SGFEF has a market cap of 5.2B. Regarding current trading prices, CHALF is priced at $0.00, while SGFEF trades at $114.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas SGFEF's P/E ratio is 25.24. In terms of profitability, CHALF's ROE is +0.00%, compared to SGFEF's ROE of +0.11%. Regarding short-term risk, CHALF is more volatile compared to SGFEF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check SGFEF's competition here
CHALF vs WIBFF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, WIBFF has a market cap of 5B. Regarding current trading prices, CHALF is priced at $0.00, while WIBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas WIBFF's P/E ratio is -0.01. In terms of profitability, CHALF's ROE is +0.00%, compared to WIBFF's ROE of +0.00%. Regarding short-term risk, CHALF is less volatile compared to WIBFF. This indicates potentially lower risk in terms of short-term price fluctuations for CHALF.Check WIBFF's competition here
CHALF vs HLUBF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, HLUBF has a market cap of 4.4B. Regarding current trading prices, CHALF is priced at $0.00, while HLUBF trades at $4.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas HLUBF's P/E ratio is 9.30. In terms of profitability, CHALF's ROE is +0.00%, compared to HLUBF's ROE of +0.14%. Regarding short-term risk, CHALF is more volatile compared to HLUBF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check HLUBF's competition here
CHALF vs HLBBF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, HLBBF has a market cap of 4.1B. Regarding current trading prices, CHALF is priced at $0.00, while HLBBF trades at $5.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas HLBBF's P/E ratio is 10.10. In terms of profitability, CHALF's ROE is +0.00%, compared to HLBBF's ROE of +0.14%. Regarding short-term risk, CHALF is more volatile compared to HLBBF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check HLBBF's competition here
CHALF vs SMDPY Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, SMDPY has a market cap of 3.8B. Regarding current trading prices, CHALF is priced at $0.00, while SMDPY trades at $9.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas SMDPY's P/E ratio is 24.03. In terms of profitability, CHALF's ROE is +0.00%, compared to SMDPY's ROE of +0.15%. Regarding short-term risk, CHALF is more volatile compared to SMDPY. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check SMDPY's competition here
CHALF vs LVZPF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, LVZPF has a market cap of 3.5B. Regarding current trading prices, CHALF is priced at $0.00, while LVZPF trades at $3.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas LVZPF's P/E ratio is 11.43. In terms of profitability, CHALF's ROE is +0.00%, compared to LVZPF's ROE of +0.15%. Regarding short-term risk, CHALF is more volatile compared to LVZPF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check LVZPF's competition here
CHALF vs CHSYF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, CHSYF has a market cap of 3.3B. Regarding current trading prices, CHALF is priced at $0.00, while CHSYF trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas CHSYF's P/E ratio is 15.00. In terms of profitability, CHALF's ROE is +0.00%, compared to CHSYF's ROE of +0.09%. Regarding short-term risk, CHALF is more volatile compared to CHSYF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check CHSYF's competition here
CHALF vs ULIHF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, ULIHF has a market cap of 3.2B. Regarding current trading prices, CHALF is priced at $0.00, while ULIHF trades at $1.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas ULIHF's P/E ratio is 8.20. In terms of profitability, CHALF's ROE is +0.00%, compared to ULIHF's ROE of +0.21%. Regarding short-term risk, CHALF is more volatile compared to ULIHF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check ULIHF's competition here
CHALF vs APNHF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, APNHF has a market cap of 3.2B. Regarding current trading prices, CHALF is priced at $0.00, while APNHF trades at $7.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas APNHF's P/E ratio is 12.95. In terms of profitability, CHALF's ROE is +0.00%, compared to APNHF's ROE of +0.04%. Regarding short-term risk, CHALF is more volatile compared to APNHF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check APNHF's competition here
CHALF vs INVVY Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, INVVY has a market cap of 3B. Regarding current trading prices, CHALF is priced at $0.00, while INVVY trades at $21.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas INVVY's P/E ratio is -62.42. In terms of profitability, CHALF's ROE is +0.00%, compared to INVVY's ROE of -0.48%. Regarding short-term risk, CHALF is more volatile compared to INVVY. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check INVVY's competition here
CHALF vs IZQVF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, IZQVF has a market cap of 2.9B. Regarding current trading prices, CHALF is priced at $0.00, while IZQVF trades at $20.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas IZQVF's P/E ratio is -56.68. In terms of profitability, CHALF's ROE is +0.00%, compared to IZQVF's ROE of -0.48%. Regarding short-term risk, CHALF is more volatile compared to IZQVF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check IZQVF's competition here
CHALF vs DNPUF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, DNPUF has a market cap of 2.9B. Regarding current trading prices, CHALF is priced at $0.00, while DNPUF trades at $7.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas DNPUF's P/E ratio is 18.10. In terms of profitability, CHALF's ROE is +0.00%, compared to DNPUF's ROE of +0.15%. Regarding short-term risk, CHALF is more volatile compared to DNPUF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check DNPUF's competition here
CHALF vs HYPMY Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, HYPMY has a market cap of 2.9B. Regarding current trading prices, CHALF is priced at $0.00, while HYPMY trades at $4.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas HYPMY's P/E ratio is 19.78. In terms of profitability, CHALF's ROE is +0.00%, compared to HYPMY's ROE of +0.07%. Regarding short-term risk, CHALF is more volatile compared to HYPMY. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check HYPMY's competition here
CHALF vs LBTSF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, LBTSF has a market cap of 2.9B. Regarding current trading prices, CHALF is priced at $0.00, while LBTSF trades at $13.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas LBTSF's P/E ratio is 121.45. In terms of profitability, CHALF's ROE is +0.00%, compared to LBTSF's ROE of +0.02%. Regarding short-term risk, CHALF is more volatile compared to LBTSF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check LBTSF's competition here
CHALF vs APNHY Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, APNHY has a market cap of 2.8B. Regarding current trading prices, CHALF is priced at $0.00, while APNHY trades at $6.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas APNHY's P/E ratio is 11.36. In terms of profitability, CHALF's ROE is +0.00%, compared to APNHY's ROE of +0.05%. Regarding short-term risk, CHALF is more volatile compared to APNHY. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check APNHY's competition here
CHALF vs HMDCF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, HMDCF has a market cap of 2.8B. Regarding current trading prices, CHALF is priced at $0.00, while HMDCF trades at $3.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas HMDCF's P/E ratio is -64.10. In terms of profitability, CHALF's ROE is +0.00%, compared to HMDCF's ROE of -0.01%. Regarding short-term risk, CHALF is more volatile compared to HMDCF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check HMDCF's competition here
CHALF vs THCBF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, THCBF has a market cap of 2.4B. Regarding current trading prices, CHALF is priced at $0.00, while THCBF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas THCBF's P/E ratio is -0.10. In terms of profitability, CHALF's ROE is +0.00%, compared to THCBF's ROE of +0.00%. Regarding short-term risk, CHALF is more volatile compared to THCBF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check THCBF's competition here
CHALF vs DMPHF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, DMPHF has a market cap of 2.1B. Regarding current trading prices, CHALF is priced at $0.00, while DMPHF trades at $39.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas DMPHF's P/E ratio is 17.90. In terms of profitability, CHALF's ROE is +0.00%, compared to DMPHF's ROE of +0.17%. Regarding short-term risk, CHALF is more volatile compared to DMPHF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check DMPHF's competition here
CHALF vs HTSUF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, HTSUF has a market cap of 2.1B. Regarding current trading prices, CHALF is priced at $0.00, while HTSUF trades at $28.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas HTSUF's P/E ratio is 16.17. In terms of profitability, CHALF's ROE is +0.00%, compared to HTSUF's ROE of +0.08%. Regarding short-term risk, CHALF is more volatile compared to HTSUF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check HTSUF's competition here
CHALF vs LJUIF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, LJUIF has a market cap of 2.1B. Regarding current trading prices, CHALF is priced at $0.00, while LJUIF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas LJUIF's P/E ratio is 13.97. In terms of profitability, CHALF's ROE is +0.00%, compared to LJUIF's ROE of +0.19%. Regarding short-term risk, CHALF is more volatile compared to LJUIF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check LJUIF's competition here
CHALF vs ARSUF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, ARSUF has a market cap of 1.8B. Regarding current trading prices, CHALF is priced at $0.00, while ARSUF trades at $25.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas ARSUF's P/E ratio is 22.70. In terms of profitability, CHALF's ROE is +0.00%, compared to ARSUF's ROE of +0.16%. Regarding short-term risk, CHALF is more volatile compared to ARSUF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check ARSUF's competition here
CHALF vs TSMRF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, TSMRF has a market cap of 1.8B. Regarding current trading prices, CHALF is priced at $0.00, while TSMRF trades at $23.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas TSMRF's P/E ratio is 8.19. In terms of profitability, CHALF's ROE is +0.00%, compared to TSMRF's ROE of +0.11%. Regarding short-term risk, CHALF is more volatile compared to TSMRF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check TSMRF's competition here
CHALF vs NPNKF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, NPNKF has a market cap of 1.7B. Regarding current trading prices, CHALF is priced at $0.00, while NPNKF trades at $25.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas NPNKF's P/E ratio is 7.80. In terms of profitability, CHALF's ROE is +0.00%, compared to NPNKF's ROE of +0.14%. Regarding short-term risk, CHALF is more volatile compared to NPNKF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check NPNKF's competition here
CHALF vs CASBF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, CASBF has a market cap of 1.7B. Regarding current trading prices, CHALF is priced at $0.00, while CASBF trades at $5.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas CASBF's P/E ratio is -25.33. In terms of profitability, CHALF's ROE is +0.00%, compared to CASBF's ROE of -0.14%. Regarding short-term risk, CHALF is more volatile compared to CASBF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check CASBF's competition here
CHALF vs YIHCF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, YIHCF has a market cap of 1.6B. Regarding current trading prices, CHALF is priced at $0.00, while YIHCF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas YIHCF's P/E ratio is -5.00. In terms of profitability, CHALF's ROE is +0.00%, compared to YIHCF's ROE of +0.19%. Regarding short-term risk, CHALF is more volatile compared to YIHCF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check YIHCF's competition here
CHALF vs MITPF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, MITPF has a market cap of 1.6B. Regarding current trading prices, CHALF is priced at $0.00, while MITPF trades at $23.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas MITPF's P/E ratio is -10.81. In terms of profitability, CHALF's ROE is +0.00%, compared to MITPF's ROE of +4.92%. Regarding short-term risk, CHALF is more volatile compared to MITPF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check MITPF's competition here
CHALF vs GTBIF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, GTBIF has a market cap of 1.5B. Regarding current trading prices, CHALF is priced at $0.00, while GTBIF trades at $7.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas GTBIF's P/E ratio is 34.48. In terms of profitability, CHALF's ROE is +0.00%, compared to GTBIF's ROE of +0.03%. Regarding short-term risk, CHALF is more volatile compared to GTBIF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check GTBIF's competition here
CHALF vs KARBF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, KARBF has a market cap of 1.5B. Regarding current trading prices, CHALF is priced at $0.00, while KARBF trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas KARBF's P/E ratio is 262.50. In terms of profitability, CHALF's ROE is +0.00%, compared to KARBF's ROE of N/A. Regarding short-term risk, CHALF is more volatile compared to KARBF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check KARBF's competition here
CHALF vs EVOTF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, EVOTF has a market cap of 1.5B. Regarding current trading prices, CHALF is priced at $0.00, while EVOTF trades at $8.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas EVOTF's P/E ratio is -6.35. In terms of profitability, CHALF's ROE is +0.00%, compared to EVOTF's ROE of -0.22%. Regarding short-term risk, CHALF is more volatile compared to EVOTF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check EVOTF's competition here
CHALF vs SHEZF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, SHEZF has a market cap of 1.5B. Regarding current trading prices, CHALF is priced at $0.00, while SHEZF trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas SHEZF's P/E ratio is -23.48. In terms of profitability, CHALF's ROE is +0.00%, compared to SHEZF's ROE of +0.05%. Regarding short-term risk, CHALF is more volatile compared to SHEZF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check SHEZF's competition here
CHALF vs NPPNY Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, NPPNY has a market cap of 1.4B. Regarding current trading prices, CHALF is priced at $0.00, while NPPNY trades at $5.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas NPPNY's P/E ratio is 6.52. In terms of profitability, CHALF's ROE is +0.00%, compared to NPPNY's ROE of +0.09%. Regarding short-term risk, CHALF is more volatile compared to NPPNY. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check NPPNY's competition here
CHALF vs CHIZF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, CHIZF has a market cap of 1.4B. Regarding current trading prices, CHALF is priced at $0.00, while CHIZF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas CHIZF's P/E ratio is 13.75. In terms of profitability, CHALF's ROE is +0.00%, compared to CHIZF's ROE of +0.04%. Regarding short-term risk, CHALF is more volatile compared to CHIZF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check CHIZF's competition here
CHALF vs CURLF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, CURLF has a market cap of 1.2B. Regarding current trading prices, CHALF is priced at $0.00, while CURLF trades at $1.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas CURLF's P/E ratio is -5.42. In terms of profitability, CHALF's ROE is +0.00%, compared to CURLF's ROE of -0.25%. Regarding short-term risk, CHALF is more volatile compared to CURLF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check CURLF's competition here
CHALF vs GNMLF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, GNMLF has a market cap of 1.2B. Regarding current trading prices, CHALF is priced at $0.00, while GNMLF trades at $1.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas GNMLF's P/E ratio is 11.70. In terms of profitability, CHALF's ROE is +0.00%, compared to GNMLF's ROE of +0.12%. Regarding short-term risk, CHALF is more volatile compared to GNMLF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check GNMLF's competition here
CHALF vs SWGHF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, SWGHF has a market cap of 1.1B. Regarding current trading prices, CHALF is priced at $0.00, while SWGHF trades at $11.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas SWGHF's P/E ratio is 15.57. In terms of profitability, CHALF's ROE is +0.00%, compared to SWGHF's ROE of +0.12%. Regarding short-term risk, CHALF is more volatile compared to SWGHF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check SWGHF's competition here
CHALF vs KSPHF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, KSPHF has a market cap of 1.1B. Regarding current trading prices, CHALF is priced at $0.00, while KSPHF trades at $27.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas KSPHF's P/E ratio is 14.74. In terms of profitability, CHALF's ROE is +0.00%, compared to KSPHF's ROE of +0.06%. Regarding short-term risk, CHALF is more volatile compared to KSPHF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check KSPHF's competition here
CHALF vs KKPCF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, KKPCF has a market cap of 1B. Regarding current trading prices, CHALF is priced at $0.00, while KKPCF trades at $28.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas KKPCF's P/E ratio is 11.24. In terms of profitability, CHALF's ROE is +0.00%, compared to KKPCF's ROE of +0.09%. Regarding short-term risk, CHALF is more volatile compared to KKPCF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check KKPCF's competition here
CHALF vs BIOGY Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, BIOGY has a market cap of 986M. Regarding current trading prices, CHALF is priced at $0.00, while BIOGY trades at $9.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas BIOGY's P/E ratio is 33.62. In terms of profitability, CHALF's ROE is +0.00%, compared to BIOGY's ROE of +0.18%. Regarding short-term risk, CHALF is more volatile compared to BIOGY. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check BIOGY's competition here
CHALF vs NIKA Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, NIKA has a market cap of 972.9M. Regarding current trading prices, CHALF is priced at $0.00, while NIKA trades at $0.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas NIKA's P/E ratio is N/A. In terms of profitability, CHALF's ROE is +0.00%, compared to NIKA's ROE of +0.39%. Regarding short-term risk, CHALF is more volatile compared to NIKA. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check NIKA's competition here
CHALF vs SHPHF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, SHPHF has a market cap of 924.4M. Regarding current trading prices, CHALF is priced at $0.00, while SHPHF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas SHPHF's P/E ratio is -3.33. In terms of profitability, CHALF's ROE is +0.00%, compared to SHPHF's ROE of -0.01%. Regarding short-term risk, CHALF is more volatile compared to SHPHF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check SHPHF's competition here
CHALF vs LVTTF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, LVTTF has a market cap of 889.7M. Regarding current trading prices, CHALF is priced at $0.00, while LVTTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas LVTTF's P/E ratio is -0.02. In terms of profitability, CHALF's ROE is +0.00%, compared to LVTTF's ROE of +0.00%. Regarding short-term risk, CHALF is less volatile compared to LVTTF. This indicates potentially lower risk in terms of short-term price fluctuations for CHALF.Check LVTTF's competition here
CHALF vs TCNNF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, TCNNF has a market cap of 887.9M. Regarding current trading prices, CHALF is priced at $0.00, while TCNNF trades at $5.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas TCNNF's P/E ratio is -6.70. In terms of profitability, CHALF's ROE is +0.00%, compared to TCNNF's ROE of -0.13%. Regarding short-term risk, CHALF is more volatile compared to TCNNF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check TCNNF's competition here
CHALF vs EVRRF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, EVRRF has a market cap of 885.9M. Regarding current trading prices, CHALF is priced at $0.00, while EVRRF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas EVRRF's P/E ratio is -0.08. In terms of profitability, CHALF's ROE is +0.00%, compared to EVRRF's ROE of +2.97%. Regarding short-term risk, CHALF is more volatile compared to EVRRF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check EVRRF's competition here
CHALF vs NRXCF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, NRXCF has a market cap of 841.1M. Regarding current trading prices, CHALF is priced at $0.00, while NRXCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas NRXCF's P/E ratio is -0.22. In terms of profitability, CHALF's ROE is +0.00%, compared to NRXCF's ROE of +2.32%. Regarding short-term risk, CHALF is more volatile compared to NRXCF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check NRXCF's competition here
CHALF vs TWAPF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, TWAPF has a market cap of 828.5M. Regarding current trading prices, CHALF is priced at $0.00, while TWAPF trades at $16.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas TWAPF's P/E ratio is 6.28. In terms of profitability, CHALF's ROE is +0.00%, compared to TWAPF's ROE of +0.11%. Regarding short-term risk, CHALF is more volatile compared to TWAPF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check TWAPF's competition here
CHALF vs SWDCF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, SWDCF has a market cap of 773.6M. Regarding current trading prices, CHALF is priced at $0.00, while SWDCF trades at $4.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas SWDCF's P/E ratio is 121.00. In terms of profitability, CHALF's ROE is +0.00%, compared to SWDCF's ROE of +0.01%. Regarding short-term risk, CHALF is more volatile compared to SWDCF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check SWDCF's competition here
CHALF vs CSWYF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, CSWYF has a market cap of 758.4M. Regarding current trading prices, CHALF is priced at $0.00, while CSWYF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas CSWYF's P/E ratio is 4.78. In terms of profitability, CHALF's ROE is +0.00%, compared to CSWYF's ROE of +0.07%. Regarding short-term risk, CHALF is more volatile compared to CSWYF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check CSWYF's competition here
CHALF vs TRXPF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, TRXPF has a market cap of 690.8M. Regarding current trading prices, CHALF is priced at $0.00, while TRXPF trades at $24.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas TRXPF's P/E ratio is 25.86. In terms of profitability, CHALF's ROE is +0.00%, compared to TRXPF's ROE of +0.04%. Regarding short-term risk, CHALF is more volatile compared to TRXPF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check TRXPF's competition here
CHALF vs TRSSF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, TRSSF has a market cap of 601.9M. Regarding current trading prices, CHALF is priced at $0.00, while TRSSF trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas TRSSF's P/E ratio is -1.32. In terms of profitability, CHALF's ROE is +0.00%, compared to TRSSF's ROE of -0.32%. Regarding short-term risk, CHALF is more volatile compared to TRSSF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check TRSSF's competition here
CHALF vs ELTP Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, ELTP has a market cap of 576.1M. Regarding current trading prices, CHALF is priced at $0.00, while ELTP trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas ELTP's P/E ratio is -26.90. In terms of profitability, CHALF's ROE is +0.00%, compared to ELTP's ROE of -0.09%. Regarding short-term risk, CHALF is more volatile compared to ELTP. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check ELTP's competition here
CHALF vs PKBFF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, PKBFF has a market cap of 543.8M. Regarding current trading prices, CHALF is priced at $0.00, while PKBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas PKBFF's P/E ratio is N/A. In terms of profitability, CHALF's ROE is +0.00%, compared to PKBFF's ROE of +7.96%. Regarding short-term risk, CHALF is more volatile compared to PKBFF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check PKBFF's competition here
CHALF vs AIHLF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, AIHLF has a market cap of 543.1M. Regarding current trading prices, CHALF is priced at $0.00, while AIHLF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas AIHLF's P/E ratio is 12.50. In terms of profitability, CHALF's ROE is +0.00%, compared to AIHLF's ROE of +0.15%. Regarding short-term risk, CHALF is more volatile compared to AIHLF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check AIHLF's competition here
CHALF vs CCHWF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, CCHWF has a market cap of 521.3M. Regarding current trading prices, CHALF is priced at $0.00, while CCHWF trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas CCHWF's P/E ratio is -1.12. In terms of profitability, CHALF's ROE is +0.00%, compared to CCHWF's ROE of -7.05%. Regarding short-term risk, CHALF is more volatile compared to CCHWF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check CCHWF's competition here
CHALF vs BOIRF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, BOIRF has a market cap of 494.8M. Regarding current trading prices, CHALF is priced at $0.00, while BOIRF trades at $28.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas BOIRF's P/E ratio is 20.07. In terms of profitability, CHALF's ROE is +0.00%, compared to BOIRF's ROE of +0.06%. Regarding short-term risk, CHALF is more volatile compared to BOIRF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check BOIRF's competition here
CHALF vs PEXXF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, PEXXF has a market cap of 463.1M. Regarding current trading prices, CHALF is priced at $0.00, while PEXXF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas PEXXF's P/E ratio is 9.00. In terms of profitability, CHALF's ROE is +0.00%, compared to PEXXF's ROE of N/A. Regarding short-term risk, CHALF is more volatile compared to PEXXF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check PEXXF's competition here
CHALF vs KHTRF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, KHTRF has a market cap of 446.4M. Regarding current trading prices, CHALF is priced at $0.00, while KHTRF trades at $4.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas KHTRF's P/E ratio is 64.00. In terms of profitability, CHALF's ROE is +0.00%, compared to KHTRF's ROE of +0.01%. Regarding short-term risk, CHALF is more volatile compared to KHTRF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check KHTRF's competition here
CHALF vs AGYTF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, AGYTF has a market cap of 405.1M. Regarding current trading prices, CHALF is priced at $0.00, while AGYTF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas AGYTF's P/E ratio is -8.50. In terms of profitability, CHALF's ROE is +0.00%, compared to AGYTF's ROE of -2.67%. Regarding short-term risk, CHALF is more volatile compared to AGYTF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check AGYTF's competition here
CHALF vs HUMDF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, HUMDF has a market cap of 404M. Regarding current trading prices, CHALF is priced at $0.00, while HUMDF trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas HUMDF's P/E ratio is -13.69. In terms of profitability, CHALF's ROE is +0.00%, compared to HUMDF's ROE of +8.06%. Regarding short-term risk, CHALF is more volatile compared to HUMDF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check HUMDF's competition here
CHALF vs FFNTF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, FFNTF has a market cap of 331.9M. Regarding current trading prices, CHALF is priced at $0.00, while FFNTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas FFNTF's P/E ratio is N/A. In terms of profitability, CHALF's ROE is +0.00%, compared to FFNTF's ROE of +0.75%. Regarding short-term risk, CHALF is more volatile compared to FFNTF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check FFNTF's competition here
CHALF vs VRNOF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, VRNOF has a market cap of 300.4M. Regarding current trading prices, CHALF is priced at $0.00, while VRNOF trades at $0.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas VRNOF's P/E ratio is -0.83. In terms of profitability, CHALF's ROE is +0.00%, compared to VRNOF's ROE of -0.22%. Regarding short-term risk, CHALF is more volatile compared to VRNOF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check VRNOF's competition here
CHALF vs GLASF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, GLASF has a market cap of 291.5M. Regarding current trading prices, CHALF is priced at $0.00, while GLASF trades at $6.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas GLASF's P/E ratio is -67.22. In terms of profitability, CHALF's ROE is +0.00%, compared to GLASF's ROE of +0.07%. Regarding short-term risk, CHALF is more volatile compared to GLASF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check GLASF's competition here
CHALF vs CPHRF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, CPHRF has a market cap of 243.7M. Regarding current trading prices, CHALF is priced at $0.00, while CPHRF trades at $9.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas CPHRF's P/E ratio is 26.42. In terms of profitability, CHALF's ROE is +0.00%, compared to CPHRF's ROE of +0.09%. Regarding short-term risk, CHALF is more volatile compared to CPHRF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check CPHRF's competition here
CHALF vs CRLBF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, CRLBF has a market cap of 232.4M. Regarding current trading prices, CHALF is priced at $0.00, while CRLBF trades at $0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas CRLBF's P/E ratio is -2.87. In terms of profitability, CHALF's ROE is +0.00%, compared to CRLBF's ROE of -0.18%. Regarding short-term risk, CHALF is more volatile compared to CRLBF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check CRLBF's competition here
CHALF vs BHCCF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, BHCCF has a market cap of 225.1M. Regarding current trading prices, CHALF is priced at $0.00, while BHCCF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas BHCCF's P/E ratio is -4.57. In terms of profitability, CHALF's ROE is +0.00%, compared to BHCCF's ROE of +0.19%. Regarding short-term risk, CHALF is more volatile compared to BHCCF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check BHCCF's competition here
CHALF vs PLNHF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, PLNHF has a market cap of 202M. Regarding current trading prices, CHALF is priced at $0.00, while PLNHF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas PLNHF's P/E ratio is -3.50. In terms of profitability, CHALF's ROE is +0.00%, compared to PLNHF's ROE of -0.34%. Regarding short-term risk, CHALF is more volatile compared to PLNHF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check PLNHF's competition here
CHALF vs PHCUF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, PHCUF has a market cap of 159.9M. Regarding current trading prices, CHALF is priced at $0.00, while PHCUF trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas PHCUF's P/E ratio is 600.00. In terms of profitability, CHALF's ROE is +0.00%, compared to PHCUF's ROE of +0.00%. Regarding short-term risk, CHALF is more volatile compared to PHCUF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check PHCUF's competition here
CHALF vs CBWTF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, CBWTF has a market cap of 146.7M. Regarding current trading prices, CHALF is priced at $0.00, while CBWTF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas CBWTF's P/E ratio is 5.50. In terms of profitability, CHALF's ROE is +0.00%, compared to CBWTF's ROE of -0.15%. Regarding short-term risk, CHALF is more volatile compared to CBWTF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check CBWTF's competition here
CHALF vs COPHF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, COPHF has a market cap of 131.7M. Regarding current trading prices, CHALF is priced at $0.00, while COPHF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas COPHF's P/E ratio is -0.02. In terms of profitability, CHALF's ROE is +0.00%, compared to COPHF's ROE of -5.75%. Regarding short-term risk, CHALF is more volatile compared to COPHF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check COPHF's competition here
CHALF vs JUSHF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, JUSHF has a market cap of 127.9M. Regarding current trading prices, CHALF is priced at $0.00, while JUSHF trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas JUSHF's P/E ratio is -2.60. In terms of profitability, CHALF's ROE is +0.00%, compared to JUSHF's ROE of +1.06%. Regarding short-term risk, CHALF is more volatile compared to JUSHF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check JUSHF's competition here
CHALF vs LOVFF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, LOVFF has a market cap of 126.4M. Regarding current trading prices, CHALF is priced at $0.00, while LOVFF trades at $1.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas LOVFF's P/E ratio is 13.82. In terms of profitability, CHALF's ROE is +0.00%, compared to LOVFF's ROE of +0.15%. Regarding short-term risk, CHALF is more volatile compared to LOVFF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check LOVFF's competition here
CHALF vs STMH Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, STMH has a market cap of 125.5M. Regarding current trading prices, CHALF is priced at $0.00, while STMH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas STMH's P/E ratio is N/A. In terms of profitability, CHALF's ROE is +0.00%, compared to STMH's ROE of -2.75%. Regarding short-term risk, CHALF is less volatile compared to STMH. This indicates potentially lower risk in terms of short-term price fluctuations for CHALF.Check STMH's competition here
CHALF vs NWPN Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, NWPN has a market cap of 123.7M. Regarding current trading prices, CHALF is priced at $0.00, while NWPN trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas NWPN's P/E ratio is -0.04. In terms of profitability, CHALF's ROE is +0.00%, compared to NWPN's ROE of +0.13%. Regarding short-term risk, CHALF is less volatile compared to NWPN. This indicates potentially lower risk in terms of short-term price fluctuations for CHALF.Check NWPN's competition here
CHALF vs HLTRF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, HLTRF has a market cap of 116.5M. Regarding current trading prices, CHALF is priced at $0.00, while HLTRF trades at $3.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas HLTRF's P/E ratio is -6.49. In terms of profitability, CHALF's ROE is +0.00%, compared to HLTRF's ROE of -0.24%. Regarding short-term risk, CHALF is more volatile compared to HLTRF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check HLTRF's competition here
CHALF vs LPCUF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, LPCUF has a market cap of 110.8M. Regarding current trading prices, CHALF is priced at $0.00, while LPCUF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas LPCUF's P/E ratio is 18.82. In terms of profitability, CHALF's ROE is +0.00%, compared to LPCUF's ROE of +0.05%. Regarding short-term risk, CHALF is more volatile compared to LPCUF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check LPCUF's competition here
CHALF vs CNVCF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, CNVCF has a market cap of 109.2M. Regarding current trading prices, CHALF is priced at $0.00, while CNVCF trades at $6.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas CNVCF's P/E ratio is -5.00. In terms of profitability, CHALF's ROE is +0.00%, compared to CNVCF's ROE of +9.56%. Regarding short-term risk, CHALF is more volatile compared to CNVCF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check CNVCF's competition here
CHALF vs GRUSF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, GRUSF has a market cap of 94.9M. Regarding current trading prices, CHALF is priced at $0.00, while GRUSF trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas GRUSF's P/E ratio is -12.77. In terms of profitability, CHALF's ROE is +0.00%, compared to GRUSF's ROE of -0.89%. Regarding short-term risk, CHALF is more volatile compared to GRUSF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check GRUSF's competition here
CHALF vs BIOYF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, BIOYF has a market cap of 94.8M. Regarding current trading prices, CHALF is priced at $0.00, while BIOYF trades at $8.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas BIOYF's P/E ratio is 17.21. In terms of profitability, CHALF's ROE is +0.00%, compared to BIOYF's ROE of +0.22%. Regarding short-term risk, CHALF is more volatile compared to BIOYF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check BIOYF's competition here
CHALF vs AAWH Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, AAWH has a market cap of 94M. Regarding current trading prices, CHALF is priced at $0.00, while AAWH trades at $0.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas AAWH's P/E ratio is -1.05. In terms of profitability, CHALF's ROE is +0.00%, compared to AAWH's ROE of -1.05%. Regarding short-term risk, CHALF is more volatile compared to AAWH. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check AAWH's competition here
CHALF vs LRDSF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, LRDSF has a market cap of 83.7M. Regarding current trading prices, CHALF is priced at $0.00, while LRDSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas LRDSF's P/E ratio is -0.01. In terms of profitability, CHALF's ROE is +0.00%, compared to LRDSF's ROE of +1.61%. Regarding short-term risk, CHALF is more volatile compared to LRDSF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check LRDSF's competition here
CHALF vs ABSCF Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, ABSCF has a market cap of 77.4M. Regarding current trading prices, CHALF is priced at $0.00, while ABSCF trades at $1.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas ABSCF's P/E ratio is -7.41. In terms of profitability, CHALF's ROE is +0.00%, compared to ABSCF's ROE of +0.32%. Regarding short-term risk, CHALF is more volatile compared to ABSCF. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check ABSCF's competition here
CHALF vs EOFBY Comparison August 2025
CHALF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHALF stands at 11.6M. In comparison, EOFBY has a market cap of 73.7M. Regarding current trading prices, CHALF is priced at $0.00, while EOFBY trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHALF currently has a P/E ratio of N/A, whereas EOFBY's P/E ratio is -7.67. In terms of profitability, CHALF's ROE is +0.00%, compared to EOFBY's ROE of N/A. Regarding short-term risk, CHALF is more volatile compared to EOFBY. This indicates potentially higher risk in terms of short-term price fluctuations for CHALF.Check EOFBY's competition here